ST80
ST80 is an inhibitor for interaction of OTUD4 and CD73. ST80 decreases CD73 protein level, increases CD73 protein turnover, reduces immune evasion of tumor cells, and thus exhibits antitumor efficacy against immunosuppressive triple-negative breast cancer (TNBC).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3080717-78-5
- Fòrmula: C26H24FN5O2
- Peso molecular:457.50
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 3080717-78-5
-
Peso molecular 457.50
-
Fòrmula C26H24FN5O2
-
SMILES
O=C1N(C2=NN([C@@H](C3=CC=C(F)C=C3)C[C@@H](C4=CC=C(C)C=C4)N5)C5=N2)C([C@@]6([H])CC=CC[C@]61[H])=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Process of PD-1/PD-L1-Mediated Tumor Immune Evasion
PD-1/PD-L1-mediated tumor immune evasion is a central mechanism by which tumors suppress antitumor immunity through immune checkpoint signaling.
2026-06-18
-
Topics Escape Route Built by TGF-β Signaling
Escape route built by TGF-β signaling refers to the immunosuppressive and stromal remodeling program through which tumors avoid immune elimination and reduce response to cancer immunotherapy.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)